This trial is active, not recruiting.

Conditions spinocerebellar ataxias, spastic paraplegias
Phase phase 1
Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Collaborator Assistance Publique - Hôpitaux de Paris
Start date May 2005
End date December 2012
Trial size 225 participants
Trial identifier NCT00136630, RBM01-59 _ AOM03059


The autosomal dominant spinocerebellar degenerations are a highly heterogeneous, clinically and genetically, group of rare diseases and of severe evolution. So far, the responsible genes for less than 50% of the cases are known and because of their rarity, there are no phenotype-genotype correlations and well-defined disease history.

The aims of the project are to develop and validate quantitative tools of the cerebellar syndrome and of the spasticity, to establish links between the phenotype and the result of the molecular analysis, to identify new loci/genes responsible for these disorders, and to establish the natural history of the disease according to the genotype.

To this end, a prospective and multicentric study is proposed for recruiting and evaluating, clinically, a cohort of 225 patients; 150 of them are already followed-up in the centers involved. A DNA collection will be set up in order to search for the implication of new loci and genes. A clinico-genetic database will be set up combining data from successive clinical evaluations and those of genotyping.

This strategy will allow access to genetic counselling and molecular diagnosis (positive, presymptomatic or prenatal diagnoses), based on a rational strategy from phenotype-genotype correlations and the information concerning the relative frequency of the genes. The detailed description, with the help of new evaluation tools and of the follow-up of the natural history of the disease according to the genotype, constitutes a crucial step in the design of therapeutical trials in these orphan disorders. Furthermore, the regular follow-up by specialized centers will allow better care of the patients.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model family-based
Time perspective prospective

Eligibility Criteria

Male or female participants from 18 years up to 80 years old.

Inclusion Criteria: - Progressive ataxia or paraplegia, - Familial history of the disease (patients), - Over 18 years of age - No presentation of neurological or osteoarticular disorders Exclusion Criteria: - Refusal to participate in the protocol, - An unknown familial history, - Presenting with an interrecurrent disorder making the evaluation of the disease (stroke, dementia) impossible

Additional Information

Official title Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
Principal investigator Alexandra Dürr, MD, PhD
Trial information was received from ClinicalTrials.gov and was last updated in January 2012.
Information provided to ClinicalTrials.gov by Institut National de la Santé Et de la Recherche Médicale, France.